Please login to the form below

Not currently logged in
Email:
Password:

Kymab names Anne Hyland as chief financial officer

Hyland joins from BBI Diagnostics
Anne Hyland

Biopharma firm Kymab has appointed Anne Hyland as chief financial officer, effective from March 1.

Hyland has more than 25 years of financial experience with both public and private firms, most recently serving as chief financial offer (CFO) at BBI Diagnostics and Vectura Group. She additionally serves as non-executive director and chair of the audit committee of Elementis.

Commenting on her appointment, Hyland said: “I am delighted to join Kymab at this exciting time. The significant level of investment the company and management team has attracted is impressive.

“Kymab is a company with tremendous capabilities and talented people and I look forward to helping build further growth and value.”

Prior to her 11-year stint at Vectura, Hyland held roles at Medeva as UK finance director and at KPMG, where she was audit manager.

Dr David Chiswell, chairman and interim CEO of Kymab, said: “I am very pleased to welcome Anne to Kymab's senior management team. Anne is an experienced CFO with a successful track record of creating value and growth for both public and private companies. Anne's strong skill set will be invaluable as we build Kymab into a substantial global biopharmaceutical company.”

Kymab is a biopharma firm with a focus on the discovery and development of biologics using its proprietary Kymouse antibody platform.

23rd February 2015

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....